【摘 要】
：
N-n-Butyl haloperidol iodide(F2)is a novel compound that has antiproliferative and antifibrogenic activities.In this study we investigated the therapeutic potential of F2 against liver fibrosis in mice and the underlying mechanisms.Two widely used mouse m
【机 构】
：
Department of Pharmacology,Shantou University Medical College,Shantou 515041,China;Qingyuan Maternal
论文部分内容阅读
N-n-Butyl haloperidol iodide(F2)is a novel compound that has antiproliferative and antifibrogenic activities.In this study we investigated the therapeutic potential of F2 against liver fibrosis in mice and the underlying mechanisms.Two widely used mouse models of fibrosis was established in mice by injection of either carbon tetrachloride(CCI4)or thioacetamide(TAA).The mice received F2(0.75,1.5 or 3 mg·kg-1·d-1,ip)for 4 weeks of fibrosis induction.We showed that F2 administration dose-dependently ameliorated CCI4-or TAA-induced liver fibrosis,evidenced by significant decreases in collagen deposition and c-Jun,TGF-β receptor II(TGFBR2),α-smooth muscle actin(α-SMA),and collagen I expression in the liver.In transforming growth factor beta 1(TGF-β1)-stimulated LX-2 cells(a human hepatic stellate cell line)and primary mouse hepatic stellate cells,treatment with F2(0.1,1,10 μM)concentration-dependently inhibited the expression of α-SMA,and collagen I.In LX-2 cells,F2 inhibited TGF-β/Smad signaling through reducing the levels of TGFBR2;pretreatment with LY2109761(TGF-β signaling inhibitor)or SP600125(c-Jun signaling inhibitor)markedly inhibited TGF-β1-induced induction of α-SMA and collagen I.Knockdown of c-Jun decreased TGF-β signaling genes,including TGFBR2 levels.We revealed that c-Jun was bound to the TGFBR2 promoter,whereas F2 suppressed the binding of c-Jun to the TGFBR2 promoter to restrain TGF-β signaling and inhibit α-SMA and collagen I upregulation.In conclusion,the therapeutic benefit of F2 against liver fibrosis results from inhibition of c-Jun expression to reduce TGFBR2 and concomitant reduction of the responsiveness of hepatic stellate cells to TGF-β1.F2 may thus be a potentially new effective pharmacotherapy for human liver fibrosis.
其他文献
目的:建立盐酸氨溴索口服液中抑菌剂及矫味剂含量测定方法并考察全国范围内该品种抑菌剂和矫味剂添加情况.方法:采用资生堂MGII C18(250 mm×4.6 mm,5μm)色谱柱,以0.02 mol·L-1乙酸铵溶液(用冰醋酸调节pH至4.5)-甲醇为流动相,梯度洗脱,流速1.0 mL·min-1,柱温为30℃,DAD检测器,检测波长为254 nm和230 nm.结果:盐酸氨溴索与4种抑菌剂、3种矫味剂色谱峰均能良好分离,并质量浓度分别在0.005～0.15 mg· mL-1范围内,苯甲酸钠(r=1.000
High mobility group box 1(HMGB1)is a ubiquitous nuclear protein that is present in almost all cells and regulates the activity of innate immune responses in both intracellular and extracellular settings.Current evidence suggests that HMGB1 plays a pivotal
Previous reports suggested that cinnamaldehyde(CA),the bioactive ingredient in Cinnamomum cassia,can suppress tumor growth,migratory,and invasive abilities.However,the role and molecular mechanisms of CA in GC are not completely understood.In the present
Hepatocellular carcinoma(HCC),the most prevalent liver cancer,is considered one of the most lethal malignancies with a dismal outcome mainly due to frequent intrahepatic and distant metastasis.In the present study,we demonstrated that oroxylin A,a natural
The tumor suppressor p53 is usually inactivated by somatic mutations in malignant neoplasms,and its reactivation represents an attractive therapeutic strategy for cancers.Here,we reported that a new quinolone compound RYL-687 significantly inhibited non-s
White matter injury is the major pathological alteration of subcortical ischemic vascular dementia(SIVD)caused by chronic cerebral hypoperfusion.It is characterized by progressive demyelination,apoptosis of oligodendrocytes and microglial activation,which
As a member of the potassium calcium-activated channel subfamily,increasing evidence suggests that KCNN4 was associated with malignancies.However,the roles and regulatory mechanisms of KCNN4 in PDAC have been little explored.In this work,we demonstrated t
Urate transporter 1(URAT1)and glucose transporter 9(GLUT9)are important targets for the development of uric acid-lowering drugs.We previously showed that the flexible linkers of URAT1 inhibitors could enhance their potency.In this study we designed and sy
Rheumatoid arthritis(RA)is a chronic systemic autoimmune disease characterized by synovitis and the destruction of small joints.Emerging evidence shows that immunoglobulin D(IgD)stimulation induces T-cell activation,which may contribute to diseases pathog
Our previous study showed that chronic treatment with tumor necrosis factor-α(TNF-α)decreased cAMP concentration in fibroblast-like synoviocytes(FLSs)of collagen-induced arthritis(CIA)rats.In this study we investigated how TNF-α impairs cAMP homeostasis,p